Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): a randomised, open-label, multicentre, phase 3 trial
Published Online: 2023-05-?
Journal: The Lancet•Publisher: Elsevier BV
Authors: Anne Armstrong•Anton Egorov•Cai Wu•Changan Chu•Dhiraj Gambhire•Elgene Lim•Fabrice André•Flora Zagouri•Francois P Duhoux•Giampaolo Bianchini•Giuliano Borges•Ian Krop•Jillian Cathcart•Joao Paulo Lima•Joaquin Gavila Gregori•Johannes Ettl•Manuel Ruiz Borrego•Michelino De Laurentiis•Rajni Sinha•Rebecca Roylance•Rinat Yerushalmi•Seock-Ah Im•Sercan Aksoy•Sung-Bae Kim•Tanja Fehm•Toshimi Takano•Yasuo Miyoshi•Yeon Hee Park
